Dipeptidyl Peptidase-IV Inhibitors: An Evolving Treatment for Type 2 Diabetes from the Incretin Concept
Publisher： Bentham Science Publishers
E-ISSN： 2212-3334|1|1|15-24
ISSN： 1872-2148
Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.1, Iss.1, 2007-02, pp. : 15-24
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
